drugset / Trial / NCT01350934

A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)

NCT01350934

Phase 4 Completed 219 enrolled Organon and Co
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate whether the once weekly administration of the combination tablet alendronate/vitamin D3 (FOSAMAX PLUS) will increase lumbar spine bone mineral density (BMD) more than the daily use of calcitriol.

Timeline

Start
2011-06-19
Primary completion
2013-01-10
Completion
2013-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Alendronic Acid Small molecule 70 mg Oral
Comparator Calcitriol Small molecule 0.25 ug Oral
Subject Cholecalciferol Other / unclassified 5600 iu Oral